πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 30 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11058704

Inhibitors of adenosine 5β€²-nucleotidase

Arcus Biosciences, Inc. Β· Granted Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11045472

Quinazoline-pyridine derivatives for the treatment of cancer-related disorders

Arcus Biosciences, Inc. Β· Granted Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11001603

Modulators of 5β€²-nucleotidase, ecto and the use thereof

Arcus Biosciences, Inc. Β· Granted Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10981944

Modulators of 5β€²-nucleotidase, ecto and the use thereof

Arcus Biosciences, Inc. Β· Granted Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10399962

Azolopyrimidine for the treatment of cancer-related disorders

Arcus Biosciences, Inc. Β· Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10239912

Modulators of 5β€²-nucleotidase, ecto and the use thereof

Arcus Biosciences, Inc. Β· Granted Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted